ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Pfizer applies for Japan COVID-19 vaccine approval

Inoculations set to begin by March after 'thorough' vetting process

The Pfizer-BioNTech COVID-19 vaccine has already received approval for emergency use in several countries, including the U.S., UK, and Singapore.    © Reuters

TOKYO -- U.S. drugmaker Pfizer on Friday applied to Japan's Ministry of Health for approval of its coronavirus vaccine, the company announced. The pharmaceutical giant is the first supplier to seek formal approval in Japan and has already agreed to supply the country with 120 million doses, enough for 60 million people.

The U.K. at the beginning of December was the first to approve Pfizer's vaccine, and inoculations began there last week. The U.S. and Canada have since followed.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more